New energy Special Report; CureVac sues Moderna; landmark Hikma hearing; EU on USTR watchlist; Samsung v ZTE ruling; plus much more IAM 3d
Moderna sued by CureVac, continuing covid jab maker’s highly eventful start to 2026 IAM 13:48 Tue, 28 Apr
Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales The Economic Times 5d All sources
CureVac patent suit targets Moderna’s spikevax Covid-19 shots Bloomberg Law 17:57 Mon, 27 Apr CureVac
Pivotal trial of Moderna's H5N1 bird flu jab gets underway pharmaphorum 11:35 Wed, 22 Apr H5N1 Pharma
